AnalystsNick AbbottNick Abbott's Stock Forecasts
AnalystsNick Abbott
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#3799 out of 4565 analysts
Average Return
-39.1%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good
Nick Abbott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Zymeworks IncZYME | +1.15% | $6.11 | $6.18 | 2022-10-03 - 2023-10-03 | Strong Buy |
Nick Abbott Analyst Color
Get additional color on Nick Abbott's coverage of popular stocks
Nick Abbott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | 1 | Strong Buy | $9.00 | N/A | Assumes | 2 years ago |
Alaunos Therapeutics IncTCRT | 2 | Strong Buy | $45.00 | N/A | Assumes | 2 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Calithera Biosciences IncCALA | 1 | Hold | $40.00 | N/A | Maintains | 2 years ago |
Cellectis SaCLLS | 1 | Hold | $16.00 | N/A | Downgrades | 2 years ago |
Affimed NvAFMD | 1 | Strong Buy | $150.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.